Major histocompatibility complex (MHC) gene products control the repertoire of T cell responses that an individual may create against pathogens and foreign tissues. This text will review the current understanding of MHC genetics in nonhuman primates, with a focus on Mauritian-origin cynomolgus macaques (Macaca fascicularis) and Indian-origin rhesus macaques (Macaca mulatta). These closely related macaque species provide important experimental models for studies of infectious disease pathogenesis, vaccine development, and transplantation research. Recent advances resulting from the application of several cost effective, highthroughput approaches, with deep sequencing technologies have revolutionized our ability to perform MHC genotyping of large macaque cohorts. Pyrosequencing of cDNA amplicons with a Roche/454 GS Junior instrument, provides excellent resolution of MHC class I allelic variants with semi-quantitative estimates of relative levels of transcript abundance. Introduction of the Illumina MiSeq platform significantly increased the sample throughput, since the sample loading workflow is considerably less labor intensive, and each instrument run yields approximately 100-fold more sequence data. Extension of these sequencing methods from cDNA to genomic DNA amplicons further streamlines the experimental workflow and opened opportunities for retrospective MHC genotyping of banked DNA samples. To facilitate the reporting of MHC genotypes, and comparisons between groups of macaques, this text also introduces an intuitive series of abbreviated rhesus MHC haplotype designations based on a major Mamu-A or Mamu-B transcript characteristic for ancestral allele combinations. The authors believe that the use of MHC-defined macaques promises to improve the reproducibility, and predictability of results from pre-clinical studies for translation to humans.
Introduction to Macaque MHC Genetics
T he MHC encodes a wealth of gene products that play crucial roles in regards to host immune responses to infection, and the rejection of allogeneic tissue transplants (Horton et al. 2004) . Primary among these are the MHC class I proteins that contain highly polymorphic peptide binding domains, which function to display short peptides derived from intracellular sources on the cell surface for surveillance by CD8+ T cells (Bontrop 2006) . Over the past decade a major focus of immunogenetic research with macaques, has been the identification and characterization of CD8+ T cell responses against simian immunodeficiency virus (SIV) in support of vaccine development Goulder and Watkins 2008; Mudd et al. 2012; Valentine and Watkins 2008) . Individual macaques express distinct complements of MHC class I proteins that restrict these immune responses by presenting specific subsets of SIV-derived peptides to CD8+ T cells, and targeting infected cells for killing. These studies have been stimulated by the observation of associations between the expression of certain rhesus macaque MHC class I alleles (e.g. Mamu-A1*001, Mamu-B*017, Mamu-B*008) and exceptional control of SIV replication Yant et al. 2006) . These findings mirror comparable observations of protection with human immunodeficiency virus (HIV)-infected patients carrying class I alleles such as HLA-B*027 and HLA-B*057 (Carrington and O'Brien 2003; Loffredo et al. 2009 ). In fact, a large genome wide association study by the International HIV Controllers Study revealed that all single nucleotide polymorphisms with genome-wide significance were concentrated in the MHC class I region, and highlighted the importance of peptide-MHC interactions for the control of HIV replication (Pereyra et al. 2010) . Given the rapidly growing understanding of macaque MHC genetics, it is expected that analogous MHC associations will be identified in the coming years for protection or susceptibility versus a variety of infectious agents beyond immunodeficiency viruses.
Although the MHC's primary role revolves around various aspects of protective immunity against infectious agents, mouse geneticists noted the importance of this genomic region more than seventy-five years ago, based on the ability of MHC gene products to confer tolerance or rejection of transplanted tissues (Snell 1981) . Despite the tremendous insights about transplantation that have been gained from studies with inbred mice, macaques still provide essential preclinical models for evaluating transplant strategies. Approaches developed in mice have often met with limited success during attempts to translate them into clinical practice (Hale et al. 2005 ). Thanks to NIH-sponsored initiatives, and the molecular genetic techniques described below, there are now pedigreed, MHC-defined macaque breeding colonies at multiple primate centers that can supply animals with known levels of MHC disparity to transplant researchers . The use of these MHC-defined macaques as donors and recipients offers the promise of improved reproducibility and predictability of tolerance-induction trials with solid organs, as well as evaluation of exciting new possibilities provided by stem cell derivatives Deleidi et al. 2011) .
While the overall organization of the MHC is more highly conserved between macaques and humans, than with mice or other model organisms, there are several important distinctions. In contrast to human MHC haplotypes which each contain only three highly polymorphic class I genes (HLA-A, HLA-B, and HLA-C), genomic analyses of the MHC region in macaques (Daza-Vamenta et al. 2004; Fukami-Kobayashi et al. 2005; Watanabe et al. 2007 ) demonstrate that the class I loci have undergone significant expansion due to multiple complex rounds of gene duplication, deletion, and rearrangement as illustrated in Figure 1 . Thus, a typical rhesus MHC haplotype may contain two or three expressed Mamu-A genes, and up to nineteen distinct Mamu-B-like loci (DazaVamenta et al. 2004; Doxiadis et al. 2011; Doxiadis et al. 2009; Fukami-Kobayashi et al. 2005; Otting et al. 2005) . Based on genomic and cDNA sequencing, a sizeable fraction of these macaque MHC loci are nonfunctional pseudogenes, this factor is due to the accumulation of frameshift mutations and premature stop codons. This additional layer of complexity results in exceptional copy number variation of the functional class I gene content between macaque MHC haplotypes. Finally, the steady state levels of macaque class I transcripts in whole blood samples vary over more than two orders of magnitude in a reproducible manner between loci (Budde et al. 2010; Wiseman et al. 2009 ). These dramatic differences in RNA levels have led to an operational distinction between "major" and "minor" class I transcripts in macaques Otting et al. 2008) ; although HLA-C transcript levels may be somewhat lower than HLA-A and HLA-B, these differences appear to be quite modest in humans compared to those in macaques . These apparent distinctions between the MHC of macaques and humans may be reconciled at least partially by the authors' recent observations that the subset of transcriptionally abundant, major class I alleles appear to be principally responsible for presenting SIV-derived peptides to CD8+ T cells in macaques (Budde et al. 2011) .
Simplifying the Complex MHC Genetics of Macaques
The MHC has been aptly described as the most polymorphic region of vertebrate genomes. Extended MHC haplotypes that segregate in a stable manner over multiple generations have been characterized within breeding groups of captive macaques. Early work by Dutch investigators employed serological techniques to identify approximately 40 Mamu-A, -B and -DR haplotypes in rhesus macaques (Van Rood et al. 1971; Bontrop et al. 1995) . Hundreds of distinct macaque MHC haplotypes have been described since Dr. Cecilia Penedo, and coworkers, established microsatellite analysis for this purpose, allowing breeding colony managers to accurately establish pedigree records (Penedo et al. 2005) . With this technique, highly variable length polymorphisms of short tandem repeats across the MHC region are amplified, and size differences of the resulting PCR products are determined by electrophoresis. Until recently, the vast majority of biomedical studies with macaques have been performed with little or no MHC information for the individual animals being examined. Since the introduction of a Mamu-A1*001 assay for PCR amplification with sequence-specific primers (PCR-SSP), by Dr. David Watkins' laboratory in 1997 (Knapp et al. 1997 ), Indian rhesus macaques have commonly been MHC genotyped with limited panels of PCR-SSP assays (Kaizu et al. 2007 ) that detect the presence or absence of a handful of specific class I and class II allelic variants, or closely related allele families (allele lineages). As of the end of 2012, a total of 2867 class I and class II sequences have been archived by the curators of the Immuno Polymorphism Database-MHC NHP database for rhesus, cynomolgus, and pig-tailed macaques that are commonly used in biomedical research (de Groot et al. 2012; Robinson et al. 2013) . MHC allele sequences for each of these species are designated with prefixes of Mamu, Mafa, and Mane, respectively. Many additional macaque MHC variants have been deposited in the GenBank/EMBL/DDBJ sequence database, and the numbers of allelic variants are expected to continue growing for the foreseeable future. Clearly it is untenable to continue developing and demonstrating specificity of individual PCR-SSP assays for this level of genetic diversity.
The efforts to characterize of the MHC of Mauritian cynomolgus macaques (MCM) helped when rethinking the approach to MHC genetics in nonhuman primates. This exceptional macaque population, currently numbering in the tens of thousands of individuals, is descended from a very small founder population. This population was introduced to the geographically isolated island of Mauritius, in the Indian Ocean, by European seafarers, approximately 400-500 years ago (Bonhomme et al. 2008; Sussman and Tattersall 1986) . Based on historical records and genetic analyses of mitochondrial and Y chromosome DNA, the founders of this exotic invasive population appear to have originated primarily from the Indonesian islands (Lawler et al. 1995; Tosi and Coke 2007) . As a consequence of their unusual population history, MHC diversity is extremely restricted in MCM compared to all other macaque populations. They have seven distinct, extended MHC haplotypes; accounting for essentially all variation in these animals (Krebs et al. 2005; Wiseman et al. 2007) . Initially these MHC haplotypes were defined using a panel of microsatellite PCR assays that spanned the 5 Mb genomic region encompassing the macaque MHC ( Figure 2A) . A useful corollary of this limited diversity was that the MHC-homozygous individuals were identifiable by microsatellite analysis, and were unambiguously assigned specific Mafa class I and class II alleles to each haplotype ( Figure 2B ) by cloning and sequencing of full length cDNA-PCR products Wiseman et al. 2007) .
The most common M1 haplotype represents nearly 20% of all MCM MHC chromosome regions ( Figure 2C ) and approximately one in every twenty-five individuals is homozygous for this extended MHC haplotype . While transcripts from the class II region are quite comparable to a typical human HLA haplotype, as illustrated in Figure 2B , the class I region of this haplotype encodes one major, and two minor Mafa-A transcripts-plus five major Mafa-B and four minor Mafa-B transcripts (Budde et al. 2010; O'Connor et al. 2007; Wiseman et al. 2007 ). Recombinant MHC haplotypes, like the example illustrated in Figure 2 , have accumulated due to simple crossover events during the ∼100 generations since the founders of the population arrived on Mauritius. Currently these recombinant MHC haplotypes account for approximately one third of MHC chromosome regions in the MCM population ). The breakpoints for these recombinant MHC haplotypes generally fit within the ∼1 Mb chromosomal intervals between the Mafa-A and Mafa-B, or Mafa-B and Mafa-DR regions, respectively. This recombination phenomenon extends to all other nonhuman primate species that have been studied to date, and is likely to play an important role in maintaining immunogenetic diversity. Thus, the macaque MHC region appears to be composed of multiple building blocks-represented by physically linked, ancestral clusters of class I A, class I B, and class II genes that have been shuffled by recombination on a relatively independent basis at the population level.
Based on these observations of restricted MHC diversity in MCM, the authors' laboratory has now been able to carry out multiple SIV challenge studies with experimental groups of heterozygous and homozygous MHC-matched animals Burwitz et al. 2009; O'Connor et al. 2010; O'Connor et al. 2012; Wiseman et al. 2007 ). In contrast to most studies of this kind, where macaques have only been selected for the presence (or absence) of one or a few specific class I alleles, the use of MCM makes it possible to carry out experiments with groups of macaques that are completely matched for all class I and class II alleles together with the wealth of immunity related genes that lie within the MHC region (e.g. complement proteins, inflammatory cytokines, antigen processing proteins, etc.). The relative ease of obtaining MHC-identical MCM has also provided the opportunity of performing allogeneic adoptive lymphocyte transfers between histocompatibile macaques; these studies had previously only been possible with inbred strains of experimental animals (Greene et al. 2008) . Conversely, microsatellite genotyping of MCM allows transplant researchers to control the degree of MHC disparity between donors and recipients (Nadazdin et al. 2010) .
A second major insight concerning macaque MHC genetics arose from the authors' efforts to identify CD8+ T cell responses that were restricted by the collection of alleles contained on individual MCM haplotypes, rather than focusing on individual class I alleles one by one. Another exceptional property of the MCM population is that nearly 90% of these animals share expression of three closely related Mafa-A transcripts that are carried on the most common M1, M2, and M3 MHC haplotypes ( Figure 2B ). Based on this observation, the SIV epitopes that are defined are restricted by two of these class I A proteins (Mafa-A1*063 and Mafa-A4*01), together with their respective peptide binding motifs, allow investigators working with other pathogens to predict CD8+ T cell responses that may be mounted by the majority of MCM (Burwitz et al. 2009 ). These studies have been extended with the characterizing of class I alleles, restricted SIVspecific CD8 T cell responses, in M3 homozygous MCM ). This common MCM MHC haplotype encodes four major, and six minor class I transcripts (Figure 2B) . Interestingly, all but one of seventeen epitopes, that were identified by scanning the SIV proteome with IFN-γ ELISPOT assays, were restricted by the three most transcriptionally abundant alleles on the M3 MHC haplotype. Recent work by the authors' laboratory has extended these findings for major class I alleles on each of the remaining six MCM MHC haplotypes (manuscript in preparation). A review of the literature showed that each of the twenty macaque MHC class I alleles, that had been reported previously to restrict CD8+ T cell responses against SIV, also all exhibited relatively abundant steady state RNA levels . Taken together, these observations have led the authors to propose that investigators interested in CD8+ T cell epitope discovery should prioritize the most transcriptionally abundant subset of macaque class I alleles from among the nearly 3000 variants that have been described to date.
Deep Sequencing a Way to an Understanding of Macaque MHC Haplotypes
Most macaque MHC class I alleles have been characterized by cloning cDNA-PCR products that span the majority of the open reading frame (Boyson et al. 1996 , while MHC class II alleles have often been limited to cloning of gDNA-PCR products containing the highly polymorphic peptide-binding domain that is encoded by exon 2 (Blancher et al. 2006; Doxiadis et al. 2007) . A variation of this cloning paradigm was made to generate a full length cDNA library from each macaque, followed by hybrid selection with conserved oligonucleotides to enrich for class I or class II sequences . In each case, characterization of the resulting clones required Sanger sequencing of three or more independent plasmids from a single individual or group of animals in order to reduce sequence artifacts associated with Taq polymerase and/or reverse transcription. Requirements to transform bacteria, isolate plasmid clones, and purify individual templates for Sanger sequencing made each of these approaches very labor intensive ). Thus, there was difficultly when processing more than a few animals in parallel, and the number of clones that could be evaluated per animal was also limited (generally 24-192/animal). These constraints meant that only the most abundant MHC transcripts expressed by an animal could be detected reproducibly, and the idea of characterizing large cohorts such as an entire breeding colony seemed unattainable.
The advent of deep sequencing technologies over the past four years has revolutionized the ability to characterize the MHC of macaques. In 2009, the authors' group demonstrated that massively parallel Roche/454 pyrosequencing could be used to determine comprehensive MHC class I genotypes of pooled samples from rhesus, cynomolgus, and pig-tailed macaques ). With this approach, PCR primer pairs that bind highly conserved sites, flanking the most highly polymorphic region within class I transcripts, are used to generate universal amplicons from cDNA templates for pyrosequencing (Figure 3 ). Thousands of class I sequence reads could be identified for each animal, greatly enhancing the sensitivity for detection of rare transcripts that are less abundant at the steady state level. For example, pyrosequencing essentially doubled the number of MHC-I transcripts associated with each of the seven MCM MHC haplotypes. Perhaps more importantly, this approach provided at least semi-quantitative estimates of the relative steady state abundance of the various transcripts expressed by each animal; since cDNA templates were evaluated, providing a much finer distinction between major and minor class I transcripts than Sanger sequencing. The current, admittedly arbitrary criteria for defining major class I transcripts in macaques is that they must exceed a 4% transcript abundance relative to all sequence reads identified per animal on average.
Rapid improvements in pyrosequencing technology increased read lengths from ∼200bp up to ∼500bp. This advance led to the adoption of the SBT568 amplicon for genotyping and allele discovery (Figure 3 ). This amplicon spans most of the peptide binding domain encoded by class I transcripts and provides much higher allelic resolution than the original 190bp amplicon. This process has been successfully used for the SBT568 amplicon for MHC genotyping of rhesus, cynomolgus, and pig-tailed macaques that are commonly use in biomedical research (Budde et al. 2010; Fernandez et al. 2011; Lang Kuhs et al. 2012) . Less wellcharacterized nonhuman primate species such as Japanese macaques, African green monkeys, and sooty mangabeys genotyping has also benefited. Unique allelic resolution is generally obtained for macaque class I transcripts; although certain allele lineages are still ambiguous for multiple, closely related allelic variants due to the differences outside the area sequenced. Likewise, an analogous amplicon for class II DRB genotyping has been developed that spans from the start codon, though most of exon 3 of DRB transcripts. Another important technological advance was the introduction of the Roche/454 GS Junior platform in 2010, allowing for deep sequencing capacity available within the research laboratory, rather than submitting libraries of pooled samples to centralized sequencing service centers (Jiang et al. 2012; Loman et al. 2012 ). This laboratory-scale instrument provided the authors' group with the flexibility to sequence individual pools that contained samples from 24-48 macaques, rather than waiting to accumulate ∼8 times more samples to fill a run on a larger Roche/454 GS FLX instrument at a outside sequencing core facility.
Over the past three years, the authors' laboratory has utilized pyrosequencing to genotype more than 3650 rhesus macaque samples, including animals from various National Primate Research Centers, commercial breeders, academic laboratories, and commercial clients. Each of these assays creates a tremendous amount of sequence information; considerable effort has been invested into sequence analysis pipelines and data management. The authors have also worked to summarize these genotyping results in formats that are clear and useful to end-users (Johnson et al. 2012) . A major advance in this regard has been the introduction of a descriptive, abbreviated nomenclature for ancestral Mamu-A, and Mamu-B haplotypes that form the genomic building blocks of the macaque MHC Karl et al. 2013) . Each of these haplotypes are designated based on a diagnostic major transcript that is characteristic for a combination of class I sequences (Tables 1 and 2 ). For instance, Mamu-A001 indicates the ancestral combination of the major Mamu-A1*001:01 and minor Mamu-A2*05:04:01 transcripts. One of several major transcripts for the more complex Mamu-B haplotypes, generally the most abundant based on numbers of sequence reads, has been selected for the abbreviated haplotype designation. Thus, Mamu-B001a indicates the combination of major Mamu-B*001:01:01, -B*007:02/03 and -B*030:02 transcripts together with minor Mamu-B*057:02, -B*060:03 and -B*072:02 transcripts (Table 2) . Suffixes indicate cases of haplotype variants where diagnostic major transcripts are associated with distinct major allele lineages. For example, the Mamu-B012a and Mamu-B012b haplotypes carry major Mamu-B*012:01 and Mamu-B*030:01 transcripts in conjunction with either Mamu-B*082:02 and Mamu-B*038:01 (B012a) or Mamu-B*022:01 and Mamu-B*031:01 (B012b).
These abbreviated haplotype designations provide a convenient, informative summary of the MHC genotypes that are carried by individual animals, as well as entire cohorts. Two pairs of Mamu-A and Mamu-B haplotypes describe each animal's MHC class I genotype. In the absence of pedigree information, an animals MHC genotype can be simply summarized as a concatenated string of its four Mamu-A and Mamu-B haplotypes. Dam r04070 in Figure 4 would be A004/A023/B001a/B017a. When MHC genotypes are available for animals with known pedigree relationships, the phase of these MHC haplotypes can be also be determined. As illustrated in Figure 4 , sire r01071 transmitted MHC chromosome regions are designated as A012/B012b and A008/B043a to his offspring r12011 and r12024, respectively. Likewise, these offspring received MHC chromosome regions with the A023/B017a, or A023/B043a haplotypes from their respective dams. The Mamu-A and Mamu-B transcripts associated with each of these haplotypes are indicated below each animal in Figure 4 . The distributions of Mamu-A and Mamu-B haplotypes provide valuable comparisons of MHC diversity between different primate centers, once significant numbers of animals have been genotyped (Figure 5 ). Although there are modest differences in the frequency of specific MHC haplotypes between cohorts, a surprisingly uniform pattern of common Mamu-A and Mamu-B haplotypes have emerged for Indian-origin rhesus macaque colonies in the United States. As illustrated in Figure 5A , approximately two-thirds of all rhesus MHC chromosomes in the Wisconsin National Primate Research Center, as well as the NIAID-sponsored breeding colony at Alpha Genesis, Inc., are accounted for by five common Mamu-A haplotypes (A004, A002a, A001, A008 and A023). Likewise, ten Mamu-B haplotypes comprise a comparable proportion of the rhesus MHC chromosomes in these colonies ( Figure 5B ). This idea extends to a half dozen additional primate centers where large numbers of animals have been evaluated. Every colony that the authors have examined to date also contains one, or more, unexpected Mamu-A and/or Mamu-B haplotypes compared to the predominately Indian-origin animals at other National Primate Centers. This phenomenon is exemplified by the unusual Mamu-B017c haplotype that represented 2.2% of the MHC chromosomes at the Wisconsin National Primate Research Center (WNPRC), but was not detected in more than 444 Alpha Genesis animals (Table 2 and Figure 6 ). A review of pedigree records demonstrated that all WNPRC animals with the B017c haplotype are descended from a pair of animals that were introduced into the WNPRC breeding colony from an outside vendor twenty years ago. Unusual MHC haplotypes like these, along with at least a subset of the rare Mamu-A and Mamu-B haplotypes that appear at frequencies below 1% in various cohorts, appear to represent admixture of the predominately Indian-origin animals in US Primate Centers, with genetic material from Chinese-and/or Burmese-origin rhesus macaques. A non-Indian admixture has been confirmed for a significant subset of WNPRC animals, which carry rare MHC haplotypes, such as B017c, using a panel of Ancestry single nucleotide polymorphism (SNP) markers (https://wiki.nhprc.org:8439/display/ NHPRCEXT/AIMS+Panel) recently developed by the Genetics and Genomics Working Group of the NHPRC Consortium (S Kanthaswamy, Z Johnson, J Satkoski-Trask, DG Smith, R Ramakrishnan, J Bahk, J Ng, RW Wiseman, HM Kubisch, EJ Vallender, J Rogers, B Ferguson, unpublished data) .
A major focus of the authors' efforts over the past year has been validating an exciting, new sequencing technology that promises to dramatically improve sample throughput, and reduce MHC genotyping costs. This approach involves paired-end sequencing with an Illumina MiSeq instrument, using a universal 195bp amplicon (SBT198) that spans exon 2 of MHC class I loci (Figure 3) . The MiSeq is a laboratoryscale sequencer analogous to the Roche/454 GS Junior (Loman et al. 2012) . The MiSeq offers several important advantages over the GS Junior technology; including a greatly simplified workflow for sample preparation, and sequencer loading in addition to yields of one to five GB of sequence data per run (up to 100-fold more than a GS Junior run). This increased sequence yield permits the user to significantly increase the level of multiplexing with up to 384 samples per experiment. The MiSeq's sequencing-by-synthesis chemistry also overcomes the sequencing artifacts associated with homopolymers that are a major issue for pyrosequencing (Loman et al. 2012) . The primary disadvantage of the MiSeq is that reads lengths are limited to 250bp with current software, and reagent configurations compared to ∼500bp read lengths that are routinely obtained for the SBT568 amplicons with Roche/454 Titanium chemistry on the GS-Junior instrument. The Illumina MiSeq paired-end approach overcomes this limitation in part by sequentially sequencing 250bp in from both the 5' and 3' end of each amplicon. Currently, the use of overlap between each MiSeq paired-end read is used to strengthen the quality in the center of consensus sequences for each template, since sequence quality scores drop dramatically with distance from each sequencing primer (Masella et al. 2012) . In order to validate the MiSeq for MHC genotyping, more than a thousand rhesus macaque cDNA samples have been reanalyzed from multiple institutions that had previously been genotyped using Roche/454 pyrosequencing. These studies demonstrated that the SBT198 amplicon provides sufficient sequence information to identify Mamu-A and Mamu-B haplotypes within large Indian-origin rhesus macaque cohorts with >300 samples per MiSeq run. While minor differences in the relative transcript abundances of certain class I alleles were noted between animals with shared haplotypes, as well as between the MiSeq and Roche/ 454 results, overall these class I transcript profiles are very comparable. Excellent concordance was observed between haplotype calls based on the SBT198 MiSeq results and those reported previously in the Roche/454 studies.
Over the past year, the authors have worked to further streamline the MHC genotyping protocols by replacing cDNA with genomic DNA as the starting material for the PCR assays. Since the SBT198 amplicon falls entirely within exon 2 of class I genes (Figure 3) , PCR of gDNA and cDNA templates yield the same targets for sequencing. Genomic DNA isolations provide much greater scheduling flexibility, when compared to RNA where the blood samples must be processed immediately upon receipt to ensure RNA integrity. First-strand cDNA synthesis reactions that have proven difficult to automate are no longer required when sequencing gDNA templates. Genotyping assays, based on gDNA, offer the possibility of utilizing large repositories of DNA samples that have been banked by many Primate Centers as part of parentage testing programs. In addition, gDNA-based assays also offer the potential to work from dried blood spots collected on Whatman FTA TM cards, which are much more convenient to ship and store than whole blood samples, or viably cyropreserved cells. This MiSeq approach has been validated by comparing cDNA and gDNA results for several hundred rhesus macaques, and either template can be used for large scale MHC genotyping. For less well characterized nonhuman primate species, and other populations (e.g. pig-tailed and non-Mauritian-origin cynomolgus macaques), cDNA templates are still preferable because they exclude pseudogenes, and provide higher allelic resolution due to longer read lengths using Roche/454 pyrosequencing. Sequencing cDNA templates also provides information about relative transcript levels that is helpful in defining new haplotypes; genotyping with gDNA templates does not provide such information. The transition from cDNA to gDNA templates for MHC genotyping is an important component in decreasing costs, and scaling this technology up for truly large cohorts illustrated by the text for the WNPRC and Alpha Genesis breeding colonies ( Figure 5 ). The Future of Macaque MHC Genetics
The MHC genotyping techniques described in this text allows investigators to screen substantial numbers of animals for their studies both prospectively and retrospectively. It is now possible to select, or exclude macaques, based on entire MHC haplotypes rather than the presence or absence of a few specific MHC alleles based on PCR-SSP assays. Given the diversity of macaque populations-including even MCMs-in practical terms, this means balancing various MHC haplotypes between experimental and control groups. Retrospective MHC genotyping of animals that demonstrated exceptional responses in previous studies will be facilitated by the ability to work with gDNA rather than RNA templates. The authors believe that retrospective genotyping offers important opportunities for researchers when dissecting possible explanations of why specific animals may have responded especially well to a particular infectious agent, a specific vaccine protocol, or immune suppression regimen (Larsen et al. 2010; Patterson et al. 2011) . MHC genotyping can also provide valuable measures for breeding colony managers concerned with genetic diversity in a colony, as a function of time and between different primate centers ( Figure 5 ). Questions of how to manage the subset of animals with rare MHC haplotypes (<1% frequency) that are present in every colony, remains an important subject for further consideration. Should animals with these rare MHC haplotypes be bred more aggressively in order to increase genetic diversity within a colony? Transplant researchers may value these animals since they are generally trying to maximize MHC disparity between donor tissues and recipients . Alternatively: would it be preferable to exclude animals carrying rare MHC haplotypes from breeding, so colonies have more consistent, high frequency MHC haplotypes, which will improve the ability of investigators from different centers to compare experimental results? In the authors' experience, these rare MHC haplotypes often appear in animals with evidence of hybrid ancestry, rather than purely Indian origins. This fact is based on ancestry analyses, with a panel of SNP markers from the Genetics and Genomics Working Group of the NHPRC Consortium (S Kanthaswamy, Z Johnson, J Satkoski-Trask, DG Smith, R Ramakrishnan, J Bahk, J Ng, RW Wiseman, HM Kubisch, EJ Vallender, J Rogers, B Ferguson, unpublished data) . Given the mandate of the National Primate Research Centers to maintain Indianorigin rhesus macaques, that can no longer be exported from India (Southwick and Siddiqi 1994) , the interim approach at WNPRC is to exclude potential sires that carry rare MHC haplotypes from the SPF breeding efforts. In contrast, dams with these rare MHC haplotypes are not excluded from breeding, in order to maintain these MHC haplotypes at low levels within the gene pool, in case they are needed for future studies. Given the importance MHC genes have for a variety of major NIH research programs, the authors advocate defining the MHC genetics of all rhesus macaques in NPRC breeding programs by high throughput genotyping techniques: like those described in this review.
The authors envision a future where nearly every Indianorigin rhesus macaque is routinely MHC genotyped. In addition, the authors would like a panel of relevant epitope-specific CD8+ T cell responses, and MHC:peptide tetramer staining reagents against a variety of pathogens to be available for nearly every animal. Despite the recognition that CD8+ T cell responses are critically important in protective immunity to infectious diseases, there are still only a handful of MHC class I alleles that have been functionally characterized. Essentially nothing is known about most Indian rhesus class I alleles. SIV-specific responses restricted by only seven class I alleles (Mamu-A1*001, Mamu-A1*002, Mamu-A1*007, Mamu-A1*011, Mamu-B*001, Mamu-B*008 and Mamu-B*017) of Indian-origin rhesus macaques have been studied in detail (Allen et al. 2001; Dzuris et al. 2000; Loffredo et al. 2004; Loffredo et al. 2005; Loffredo et al. 2007b; Mothe et al. 2002; Reed et al. 2011) . Taken together, these class I alleles are only expressed by a minority of Indian-origin rhesus. This limitation is exemplified in Figure 4 , where existing reagents would only be applicable for dam r04070 and her offspring r12011 who express Mamu-B*017 and/or Mamu-B*001. Knowledge of MHC class I peptide binding motifs, and peptide epitopes that elicit CD8+ T cell responses, are an essential prerequisite for understanding cellular immunity. Once epitopespecific CD8+ T cell responses have been mapped, stimulating T cells with synthetic peptides, measuring the production of cytokines or other effector molecules will become commonplace. Fine-mapping such responses to resolve minimal, optimal epitopes increases the sensitivity of immunological assays, facilitates identification of the restricting MHC class I molecule, and enables synthesis of MHC:peptide tetramers. Tetramers allow investigators to: immunophenotype epitope-specific CD8+ T cells with single cell resolution; sensitively quantify the magnitude and strength of CD8+ T cell responses; and image individual CD8+ T cells in situ, enabling investigators to visualize host:pathogen interactions at the site of replication. To take full advantage of this expanded MHC genotyping capacity described in the text, it is essential that CD8+ T cell responses are identified against SIV, and other pathogens are restricted by common MHC class I alleles-which to date have been completely ignored.
The improvements in macaque MHC genotyping described in this review represent just the leading edge of a paradigm shift that is rapidly approaching for macaque genetics thanks to advances in genomic sequencing technologies. In collaboration with Dr. Jeffrey Rogers' laboratory at the Baylor Human Genome Sequencing Center, the authors' group is currently examining whole genome sequences of twenty MHC-matched MCMs. Given the restricted genetic diversity of this exceptional population, it is believed that this data set in conjunction with a previously published MCM genomic sequence (Ebeling et al. 2011) , will allow for the capture of the majority of the common genetic variation that is present in Mauritian cynomolgus macaques. Whole genome and exome sequencing results will soon become available for hundreds of rhesus macaques from several National Primate Research Centers (Gibbs et al. 2007; Fawcett et al. 2011; Vallender 2011; Yan et al. 2011) . Data from these studies are being used to generate high density, genome-wide, SNP arrays that will be valuable for association studies as well as efforts to monitor genetic diversity in animals across different centers. The authors anticipate combining such efforts with the analyses of complex regions of the macaque genome, such as the MHC and killer immunoglobulin-like receptor loci (Bimber et al. 2008; Moreland et al. 2011) . The cost of these genomic analyses is low when compared to the overall costs of maintaining this animal resource. It is believed that these results will enhance the understanding of existing experimental models, as well as lead to the development of valuable new models for human diseases.
